Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Inventory: 2009-2025

Historic Inventory for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $32.3 million.

  • Lifecore Biomedical's Inventory fell 19.23% to $32.3 million in Q2 2025 from the same period last year, while for May 2025 it was $32.3 million, marking a year-over-year decrease of 19.23%. This contributed to the annual value of $32.3 million for FY2025, which is 19.23% down from last year.
  • Lifecore Biomedical's Inventory amounted to $32.3 million in Q2 2025, which was down 6.66% from $34.6 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Inventory registered a high of $42.0 million during Q1 2023, and its lowest value of $31.4 million during Q1 2021.
  • In the last 3 years, Lifecore Biomedical's Inventory had a median value of $40.4 million in 2023 and averaged $39.3 million.
  • Over the last 5 years, Lifecore Biomedical's Inventory had its largest YoY gain of 27.53% in 2021, and its largest YoY loss of 53.11% in 2021.
  • Over the past 5 years, Lifecore Biomedical's Inventory (Quarterly) stood at $39.7 million in 2021, then dropped by 3.26% to $38.4 million in 2022, then climbed by 7.88% to $41.4 million in 2023, then declined by 5.39% to $39.2 million in 2024, then fell by 19.23% to $32.3 million in 2025.
  • Its last three reported values are $32.3 million in Q2 2025, $34.6 million for Q1 2025, and $39.2 million during Q4 2024.